ACTRN12620000141943招募中1 期
Phase I clinical trial of the safety of adoptive transfer of multi-virus-specific T cells into TCRaß+/CD19+-depleted haploidentical HSCT recipients
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 3 Months 至 18 Years（—）
- 性别
- All
入选标准
- •1. Aged between 3 months and 18 years
- •2. Patient has a condition for which HSCT is indicated
- •3. Transplant physician determines that optimal donor is haploidentical*
- •4. Haplo-HSCT donor is aged 18 or above
- •5. Haplo-HSCT donor is available and willing to donate blood for therapy manufacture
- •* This decision is usually based upon lack of HLA matched sibling or fully matched unrelated donor, but may be influenced by other factors such as donor availability or urgency of HSCT.
排除标准
- •The treatment protocol in part or in its entirety is declined by either the patient or their legal guardian.
- •NB: Additional criteria are in place for the commencement of infusions
研究者
相似试验
已完成
1 期
Phase I Trial of Adoptive Immunotherapy for Stage III and IV Nasopharyngeal CarcinomaNasopharyngeal Carcinomaasopharyngeal CarcinomaCancer - Head and neckACTRN12607000191493Queensland Institute of Medical Research10
尚未招募
不适用
A phase I clinical trial to study the safety of treatment with Tipifarnib (ZARNESTRA) combined with Bortezomib (VELCADE) in patients with myelodysplastic syndrome (MDS)myelodysplasiamyelodysplastic syndroom10018865NL-OMON30154niversitair Medisch Centrum Sint Radboud18
招募中
1 期
Phase I study for the efficacy and the safety of the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia.interstitial pneumonia, lung cancer, metastatic lung tumor, pneumothoraxJPRN-UMIN000003295Tokyo Women's Medical University of Medicine, Department of Surgery I30
已完成
1 期
Mesenchymal Stem Cells Transplantation in newly diagnosed Type-1 Diabetes PatientsDiabetes.Insulin-dependent diabetes mellitusIRCT2016070428786N1Royan Institute20
已完成
1 期
A trial to test the safety of a herbal formulatioCTRI/2018/02/011689SK Biolabs100